SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001594864-17-000034
Filing Date
2017-08-03
Accepted
2017-08-03 17:10:05
Documents
76
Period of Report
2017-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q juno-06302017x10q.htm 10-Q 1382020
2 EXHIBIT 10.1A exhibit101a.htm EX-10.1A 80621
3 EXHIBIT 10.1B exhibit101b.htm EX-10.1B 14722
4 EXHIBIT 10.2 exhibit102.htm EX-10.2 23853
5 EXHIBIT 31.1 ex-311x0630201710q.htm EX-31.1 12905
6 EXHIBIT 31.2 ex-312x0630201710q.htm EX-31.2 12375
7 EXHIBIT 32.1 ex-321x0630201710q.htm EX-32.1 7398
8 EXHIBIT 32.2 ex-322x0630201710q.htm EX-32.2 7400
  Complete submission text file 0001594864-17-000034.txt   6415281

Data Files

Seq Description Document Type Size
9 XBRL INSTANCE DOCUMENT juno-20170630.xml EX-101.INS 1360993
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT juno-20170630.xsd EX-101.SCH 43861
11 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT juno-20170630_cal.xml EX-101.CAL 83382
12 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT juno-20170630_def.xml EX-101.DEF 216083
13 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT juno-20170630_lab.xml EX-101.LAB 570920
14 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT juno-20170630_pre.xml EX-101.PRE 365405
Mailing Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109
Business Address 307 WESTLAKE AVENUE NORTH, SUITE 300 SEATTLE WA 98109 2065821600
Juno Therapeutics, Inc. (Filer) CIK: 0001594864 (see all company filings)

IRS No.: 463656275 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36781 | Film No.: 171005986
SIC: 2836 Biological Products, (No Diagnostic Substances)